ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,957
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
KRAS mutation: from undruggable to druggable in cancer
Author(s):
L Huang
,
Z. GUO
,
F WANG
Publication date:
2021
Journal:
Signal Transduct Target Ther
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Bioscientifica Open Endocrinology
Author and article information
Journal
DOI::
10.1038/s41392-021-00780-4
PubMed ID::
33384407
ScienceOpen disciplines:
Molecular biology
Data availability:
ScienceOpen disciplines:
Molecular biology
Comments
Comment on this article
Sign in to comment
Related Documents Log
scite_
Similar content
3,957
Drugging the undruggable proteins in cancer: a systems biology approach
Authors:
S Pathmanathan
Lipid-mediated intracellular delivery of recombinant bioPROTACs for the rapid degradation of undruggable proteins
Authors:
Alexander Chan
,
Rebecca M. Haley
,
Mohd Altaf Najar
…
Amgen overcomes historically undruggable target, with FDA nod for first KRAS inhibitor
Authors:
A. Mullard
See all similar
Cited by
1
The structure of KRAS G12C bound to divarasib highlights features of potent switch-II pocket engagement
Authors:
Micah C. Fernando
,
Gregory B. Craven
,
Kevan M. Shokat
See all cited by